{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:57:21Z","timestamp":1774022241620,"version":"3.50.1"},"reference-count":44,"publisher":"American Society of Hematology","issue":"4","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2001,8,15]]},"abstract":"<jats:p>Immunostimulatory cytosine-phophate-guanosine (CpG)\u2013containing motifs in bacterial DNA are potent immune system activators. Depending on the bases flanking the CpG motif and on the DNA backbone, CpG oligodeoxynucleotides (ODNs) can induce relatively more B-cell activation or relatively more natural killer (NK)\u2013cell activation. To evaluate their antitumor activities, an NK-optimized ODN (1585) and 2 B-cell\u2013optimized ODNs (1826 and 2006) were compared for their ability to protect naive mice against a lethal acute myelogenous leukemia (AML) challenge. CpG 2006, but not CpG 1585, administered 2 days before the AML challenge, allowed mice to survive more than 100 times a lethal tumor dose. Cell depletion studies showed that protection did not require T or B cells but depended on NK cells and also on an NK-independent mechanism. CpG 2006 protected against AML challenge in both syngeneic and allogeneic bone marrow transplant (BMT) recipients at both early and late time points after transplantation. Although CpG 1585 had no protective effect on its own, it showed a striking synergy with CpG 2006 to induce prolonged survival to AML challenge in allogeneic recipients of T-cell\u2013depleted marrow grafts, exceeding the survival benefit of donor lymphocyte infusion (DLI). When combined with DLI, a synergistic effect was observed in recipients of CpG2006 or 2006 + 1585 with 88% of mice surviving long-term. These data are the first to indicate that the systemic administration of CpG ODNs is a potent means of inducing therapeutic anti-AML innate immune responses in naive and BMT recipients.<\/jats:p>","DOI":"10.1182\/blood.v98.4.1217","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T12:46:47Z","timestamp":1027774007000},"page":"1217-1225","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":68,"title":["Synthetic unmethylated cytosine-phosphate-guanosine oligodeoxynucleotides are potent stimulators of antileukemia responses in naive and bone marrow transplant recipients"],"prefix":"10.1182","volume":"98","author":[{"given":"Bruce R.","family":"Blazar","sequence":"first","affiliation":[{"name":"From the University of Minnesota Cancer Center and Department of Pediatrics, Division of Bone Marrow Transplant, Minneapolis, MN; Department of Veteran Affairs Medical Center and the Department of Internal Medicine, University of Iowa College of Medicine, Iowa City; and the Coley Pharmaceutical Group, Wellesley, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arthur M.","family":"Krieg","sequence":"additional","affiliation":[{"name":"From the University of Minnesota Cancer Center and Department of Pediatrics, Division of Bone Marrow Transplant, Minneapolis, MN; Department of Veteran Affairs Medical Center and the Department of Internal Medicine, University of Iowa College of Medicine, Iowa City; and the Coley Pharmaceutical Group, Wellesley, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia A.","family":"Taylor","sequence":"additional","affiliation":[{"name":"From the University of Minnesota Cancer Center and Department of Pediatrics, Division of Bone Marrow Transplant, Minneapolis, MN; Department of Veteran Affairs Medical Center and the Department of Internal Medicine, University of Iowa College of Medicine, Iowa City; and the Coley Pharmaceutical Group, Wellesley, MA."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","reference":[{"key":"2020021220483624200_B1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1034\/j.1600-065X.2000.917309.x","article-title":"Immune recognition: mechanisms and pathways.","volume":"173","author":"Medzhitov","year":"2000","journal-title":"Immunol Rev."},{"key":"2020021220483624200_B2","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0952-7915(99)00048-5","article-title":"The role of CpG motifs in innate immunity.","volume":"12","author":"Krieg","year":"2000","journal-title":"Curr Opin Immunol."},{"key":"2020021220483624200_B3","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1038\/374546a0","article-title":"CpG motifs in bacterial DNA trigger direct B-cell activation.","volume":"374","author":"Krieg","year":"1995","journal-title":"Nature."},{"key":"2020021220483624200_B4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S1074-7613(00)80087-4","article-title":"Immune recognition of foreign DNA: a cure for bioterrorism.","volume":"11","author":"Klinman","year":"1999","journal-title":"Immunity."},{"key":"2020021220483624200_B5"},{"key":"2020021220483624200_B6","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/35047123","article-title":"A Toll-like receptor recognizes bacterial DNA.","volume":"408","author":"Hemmi","year":"2000","journal-title":"Nature."},{"key":"2020021220483624200_B7","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1084\/jem.186.10.1623","article-title":"CpG oligodeoxynucleotides acts as adjuvants that switch on T helper 1 (Th1) immunity.","volume":"186","author":"Chu","year":"1997","journal-title":"J Exp Med."},{"key":"2020021220483624200_B8","doi-asserted-by":"crossref","first-page":"10833","DOI":"10.1073\/pnas.94.20.10833","article-title":"Immunostimulatory oligodeoxynucleotides containing the CpG motif are effective as immune adjuvants in tumor antigen immunization.","volume":"94","author":"Weiner","year":"1997","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021220483624200_B9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nm0897-849","article-title":"Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants.","volume":"3","author":"Roman","year":"1997","journal-title":"Nat Med."},{"key":"2020021220483624200_B10","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/eji.1830270931","article-title":"CpG-containing synthetic oligonucleotides promote B and cytotoxic T cell responses to protein antigen: a new class of vaccine adjuvants.","volume":"27","author":"Lipford","year":"1997","journal-title":"Eur J Immunol."},{"key":"2020021220483624200_B11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0065-2776(08)60790-7","article-title":"Bacterial CpG DNA activates immune cells to signal infectious danger.","volume":"73","author":"Wagner","year":"1999","journal-title":"Adv Immunol."},{"key":"2020021220483624200_B12","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.4049\/jimmunol.161.6.3042","article-title":"Activation of cutaneous dendritic cells by CpG-containing oligodeoxynucleotides: a role for dendritic cells in the augmentation of Th1 responses by immunostimulatory DNA.","volume":"161","author":"Jakob","year":"1998","journal-title":"J Immunol."},{"key":"2020021220483624200_B13","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/(SICI)1521-4141(199907)29:07<2344::AID-IMMU2344>3.0.CO;2-R","article-title":"Oligodeoxynucleotides containing CpG motifs include IL-12, IL18 and IFN-y production in cells from allergic individuals and inhibit IgE synthesis in vitro.","volume":"29","author":"Bohle","year":"1999","journal-title":"Eur J Immunol."},{"key":"2020021220483624200_B14","doi-asserted-by":"crossref","first-page":"9305","DOI":"10.1073\/pnas.96.16.9305","article-title":"CpG DNA as a signal for growth, activation and maturation of human dendritic cells.","volume":"96","author":"Hartmann","year":"1999","journal-title":"Proc Natl Acad Sci U S A."},{"key":"2020021220483624200_B15","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1200\/JCO.1992.10.11.1723","article-title":"Allogeneic marrow transplantation during untreated first relapse of acute myeloid leukemia.","volume":"10","author":"Clift","year":"1992","journal-title":"J Clin Oncol."},{"key":"2020021220483624200_B16","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1200\/JCO.1987.5.9.1348","article-title":"Allogeneic bone marrow transplantation for acute lymphoblastic leukemia in remission: prolonged survival associated with acute graft-versus-host disease.","volume":"5","author":"Weisdorf","year":"1987","journal-title":"J Clin Oncol."},{"key":"2020021220483624200_B17","article-title":"Allogeneic hematopoietic cell transplantation for acute myeloid leukemia.","volume-title":"Hematopoietic Cell Transplantation.","author":"Stockeri-Goldstein","year":"1999"},{"key":"2020021220483624200_B18","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1182\/blood.V86.5.2041.bloodjournal8652041","article-title":"Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients. European Group for Blood and Marrow Transplantation Working Party Chronic Leukemia [abstract].","volume":"86","author":"Kolb","year":"1995","journal-title":"Blood."},{"key":"2020021220483624200_B19","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1200\/JCO.1997.15.2.433","article-title":"Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.","volume":"15","author":"Collins","year":"1997","journal-title":"J Clin Oncol."},{"key":"2020021220483624200_B20","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1172\/JCI114845","article-title":"Failure of T cell receptor-anti-CD3 monoclonal antibody interaction in T cells from marrow recipients to induce increases in intracellular ionized calcium.","volume":"86","author":"Yamagami","year":"1990","journal-title":"J Clin Invest."},{"key":"2020021220483624200_B21","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1182\/blood.V70.6.1893.1893","article-title":"Interleukin 2-activated killer cells in patients following transplants of soybean lectin-separated and E rosette-depleted bone marrow.","volume":"70","author":"Keever","year":"1987","journal-title":"Blood."},{"key":"2020021220483624200_B22","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1182\/blood.V73.5.1340.1340","article-title":"Immune reconstitution following bone marrow transplantation: comparison of recipients of T-cell depleted marrow with recipients of conventional marrow grafts.","volume":"73","author":"Keever","year":"1989","journal-title":"Blood."},{"key":"2020021220483624200_B23","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1182\/blood.V75.11.2250.2250","article-title":"Anti-leukemia potential of interleukin-2 activated natural killer cells after bone marrow transplantation for chronic myelogenous leukemia.","volume":"75","author":"Hauch","year":"1990","journal-title":"Blood."},{"key":"2020021220483624200_B24","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/oli.1.1996.6.133","article-title":"Oligodeoxynucleotide modifications determine the magnitude of B cell stimulation by CpG motifs.","volume":"6","author":"Krieg","year":"1996","journal-title":"Antisense Nucleic Acid Drug Dev."},{"key":"2020021220483624200_B25","first-page":"1297","article-title":"Rapid plasma clearance and metabolism in vivo of a phosphorothioate oligodeoxynucleotide with a single, internal phosphodiester bond.","volume":"23","author":"Boado","year":"1995","journal-title":"Drug Metab Dispos."},{"key":"2020021220483624200_B26","first-page":"932","article-title":"Biodistribution and metabolism of internally 3H-labeled oligonucleotides.","volume":"45","author":"Sands","year":"1994","journal-title":"Mol Pharmacol."},{"key":"2020021220483624200_B27"},{"key":"2020021220483624200_B28","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.4049\/jimmunol.161.5.2428","article-title":"CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge.","volume":"161","author":"Krieg","year":"1998","journal-title":"J Immunol."},{"key":"2020021220483624200_B29","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.4049\/jimmunol.160.8.3627","article-title":"CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis.","volume":"160","author":"Zimmermann","year":"1998","journal-title":"J Immunol."},{"key":"2020021220483624200_B30","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.4049\/jimmunol.159.7.3460","article-title":"CD28\/B7 interactions are required for sustaining the graft-versus-leukemia effect of delayed post-BMT splenocyte infusion in murine recipients of myeloid or lymphoid leukemia cells.","volume":"159","author":"Blazar","year":"1997","journal-title":"J Immunol."},{"key":"2020021220483624200_B31","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.4049\/jimmunol.157.5.1840","article-title":"Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA.","volume":"157","author":"Ballas","year":"1996","journal-title":"J Immunol."},{"key":"2020021220483624200_B32","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.4049\/jimmunol.164.3.1617","article-title":"Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo.","volume":"164","author":"Hartmann","year":"2000","journal-title":"J Immunol."},{"key":"2020021220483624200_B33","doi-asserted-by":"crossref","first-page":"944","DOI":"10.4049\/jimmunol.164.2.944","article-title":"Mechanism and function of a newly identified CpG DNA motif in human primary B-cells.","volume":"164","author":"Hartmann","year":"2000","journal-title":"J Immunol."},{"key":"2020021220483624200_B34","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1182\/blood.V89.8.2994","article-title":"Immunostimulatory oligodeoxynucleotides containing CpG motifs enhance the efficacy of monoclonal antibody therapy of lymphoma.","volume":"89","author":"Wooldridge","year":"1997","journal-title":"Blood."},{"key":"2020021220483624200_B35","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1182\/blood.V92.10.3730","article-title":"Immunostimulatory CpG oligodeoxynucleotides enhance the immune response to vaccine strategies involving granulocyte-macrophage colony-stimulating factor.","volume":"92","author":"Liu","year":"1998","journal-title":"Blood."},{"key":"2020021220483624200_B36","first-page":"5429","article-title":"Oligodeoxynucleotides containing CpG motifs can induce rejection of a neuroblastoma in mice.","volume":"59","author":"Carpentier","year":"1999","journal-title":"Cancer Res."},{"key":"2020021220483624200_B37","first-page":"2469","article-title":"Successful treatment of intracranial gliomas in rat by oligodeoxynucleotides containing CpG motifs.","volume":"6","author":"Carpentier","year":"2000","journal-title":"Clin Cancer Res."},{"key":"2020021220483624200_B38","doi-asserted-by":"crossref","first-page":"539","DOI":"10.4049\/jimmunol.165.1.539","article-title":"Repeated administration of cytosine-phosphorothiolated guanine-containing oligonucleotides together with peptide\/protein immunization results in enhanced CTL responses with anti-tumor activity.","volume":"165","author":"Davila","year":"2000","journal-title":"J Immunol."},{"key":"2020021220483624200_B39","doi-asserted-by":"crossref","first-page":"6278","DOI":"10.4049\/jimmunol.165.11.6278","article-title":"Enhanced dendritic cell maturation by TNF-alpha or cytidine-phosphate-guanosine DNA drives T cell activation in vitro and therapeutic anti-tumor immune responses in vivo.","volume":"165","author":"Brunner","year":"2000","journal-title":"J Immunol."},{"key":"2020021220483624200_B40","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/75365","article-title":"Immunostimulatory DNA-based vaccines induce cytotoxic lymphocyte activity by a T-helper cell-independent mechanism.","volume":"18","author":"Cho","year":"2000","journal-title":"Nat Biotechnol."},{"key":"2020021220483624200_B41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/7403","article-title":"Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo.","volume":"5","author":"Fernandez","year":"1999","journal-title":"Nat Med."},{"key":"2020021220483624200_B42","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1084\/jem.190.8.1155","article-title":"Human dendritic cells mediate cellular apoptosis via tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).","volume":"190","author":"Fanger","year":"1999","journal-title":"J Exp Med."},{"key":"2020021220483624200_B43","doi-asserted-by":"crossref","first-page":"4570","DOI":"10.4049\/jimmunol.156.12.4570","article-title":"Bacterial DNA induces NK cells to produce IFN-gamma in vivo and increases the toxicity of lipopolysaccharides.","volume":"156","author":"Cowdery","year":"1996","journal-title":"J Immunol."},{"key":"2020021220483624200_B44","doi-asserted-by":"crossref","first-page":"6244","DOI":"10.4049\/jimmunol.165.11.6244","article-title":"APC stimulated by CpG oligodeoxynucleotide enhance activation of MHC class I-restricted T cells.","volume":"165","author":"Warren","year":"2000","journal-title":"J Immunol."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/98\/4\/1217\/1676286\/h8160101217.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/98\/4\/1217\/1676286\/h8160101217.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,23]],"date-time":"2023-04-23T20:11:35Z","timestamp":1682280695000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/98\/4\/1217\/107179\/Synthetic-unmethylated-cytosinephosphateguanosine"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8,15]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2001,8,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.v98.4.1217","relation":{},"ISSN":["1528-0020","0006-4971"],"issn-type":[{"value":"1528-0020","type":"electronic"},{"value":"0006-4971","type":"print"}],"subject":[],"published":{"date-parts":[[2001,8,15]]}}}